A phase II trial of mitomycin in patients with epithelial ovarian carcinoma resistant to cisplatin or carboplatin. [electronic resource]
- American journal of clinical oncology Oct 1990
- 416-9 p. digital
Publication Type: Journal Article
0277-3732
10.1097/00000421-199010000-00010 doi
Adult Aged Carboplatin--therapeutic use Carcinoma--drug therapy Cisplatin--therapeutic use Drug Evaluation Drug Resistance Female Humans Leukopenia--chemically induced Middle Aged Mitomycins--adverse effects Ovarian Neoplasms--drug therapy Remission Induction Thrombocytopenia--chemically induced